undec-10-enyl 2-((S)-((2S,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxytetrahydrofuran-2-yloxy)((2S,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)-1,4-dimethyl-3-oxo-2,3,4,7-tetrahydro-1H-1,4-diazepine-5-carboxylate

ID: ALA4546475

Chembl Id: CHEMBL4546475

PubChem CID: 71652443

Max Phase: Preclinical

Molecular Formula: C33H51N5O12

Molecular Weight: 709.79

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  C=CCCCCCCCCCOC(=O)C1=CCN(C)[C@@H]([C@H](O[C@@H]2O[C@H](CN)[C@@H](O)[C@H]2O)[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2O)C(=O)N1C

Standard InChI:  InChI=1S/C33H51N5O12/c1-4-5-6-7-8-9-10-11-12-17-47-31(45)19-13-15-36(2)22(29(44)37(19)3)27(50-32-26(43)23(40)20(18-34)48-32)28-24(41)25(42)30(49-28)38-16-14-21(39)35-33(38)46/h4,13-14,16,20,22-28,30,32,40-43H,1,5-12,15,17-18,34H2,2-3H3,(H,35,39,46)/t20-,22+,23-,24+,25-,26-,27+,28+,30-,32+/m1/s1

Standard InChI Key:  PWOHTTZMPKBOMM-REFHBTEXSA-N

Associated Targets(non-human)

Mycolicibacterium phlei (631 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium tuberculosis (203094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium avium subsp. paratuberculosis (238 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium tuberculosis variant bovis (1746 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycolicibacterium smegmatis (8003 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycolicibacterium vaccae (371 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 709.79Molecular Weight (Monoisotopic): 709.3534AlogP: -1.55#Rotatable Bonds: 17
Polar Surface Area: 239.34Molecular Species: BASEHBA: 15HBD: 6
#RO5 Violations: 3HBA (Lipinski): 17HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.70CX Basic pKa: 8.75CX LogP: -0.40CX LogD: -1.54
Aromatic Rings: 1Heavy Atoms: 50QED Weighted: 0.06Np Likeness Score: 1.01

References

1. Patel B, Ryan P, Makwana V, Zunk M, Rudrawar S, Grant G..  (2019)  Caprazamycins: Promising lead structures acting on a novel antibacterial target MraY.,  171  [PMID:30933853] [10.1016/j.ejmech.2019.01.071]
2. Arbour CA,Imperiali B.  (2020)  Uridine natural products: Challenging targets and inspiration for novel small molecule inhibitors.,  28  (18): [PMID:32828427] [10.1016/j.bmc.2020.115661]

Source